Rege Nephro Co
Developing innovative therapies and medical technologies for patients with kidney diseases who currently have limited treatment options
$10.6MSeries C
Role not disclosedActivity from announced rounds
Developing innovative therapies and medical technologies for patients with kidney diseases who currently have limited treatment options